Bio-Rad Laboratories (BIO): Q4 EPS of $2.08 may not be comparable to consensus of $1.67. Revenue...

|About: Bio-Rad Laboratories, Inc. (BIO)|By:, SA News Editor
Bio-Rad Laboratories (BIO): Q4 EPS of $2.08 may not be comparable to consensus of $1.67. Revenue of $550.2M (+3.1% Y/Y) misses by $12M. Shares -0.9% AH. (PR)